The series on “Eastern and Western Perspectives on Precision Cancer Medicine” was edited by Drs Zhi-Ming Shao and Xiao-Mao Guo, Fudan University Shanghai Cancer Center, Shanghai, China.
Original Article
Comparison of cancer incidence and mortality between China and the United States
Review Article
FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology
A narrative review of microRNA therapeutics: understanding the future of microRNA research
Precision cancer medicine in China: the Fudan University Shanghai Cancer Center experience
Metabolic reprogramming and cancer precision medicine: a narrative review
Disclosure:
The series “Eastern and Western Perspectives on Precision Cancer Medicine” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Zhi-Ming Shao and Xiao-Mao Guo served as the unpaid Guest Editors for the series.